<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Karagiannakis, Dimitrios S</style></author><author><style face="normal" font="default" size="100%">Stefanaki, Katerina</style></author><author><style face="normal" font="default" size="100%">Paschou, Stavroula A</style></author><author><style face="normal" font="default" size="100%">Papatheodoridi, Margarita</style></author><author><style face="normal" font="default" size="100%">Tsiodras, Sotirios</style></author><author><style face="normal" font="default" size="100%">Papanas, Nikolaos</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Addressing the essentials of the recent guidelines for managing patients with metabolic dysfunction-associated steatotic liver disease</style></title><secondary-title><style face="normal" font="default" size="100%">Hormones</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><pages><style face="normal" font="default" size="100%">1–8</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>